OPT Opthea Ltd.: Net earnings per share for the last four quarters

Opthea Limited requires massive capital to complete OPT-302 trials, which correlates with the current state of annual EPS TTM growth on the GURU.Markets chart, where the metric value stands at -186.60. The company is challenging ophthalmology leaders and their established treatment methods. Currently, the firm is engaged in a risky race, attempting to implement breakthrough therapy and capture market share.

Opthea Corp (OPT): Earnings per share for the last twelve months from 02/11/2024 to 02/20/2024

Opthea Ltd. - analytical breakdowns and key metrics (OPT)

- price and consensus price forecast:

Market Price opthea.com|OPT - Price Target Chart

- company stock capitalization data:

Market Capitalization Opthea Ltd|OPT - Total Company Value

- book value of equity indicators:

Net Asset Value per Share Opthea|OPT - Company Book Value|Market Capitalization to Net Assets opthea.com|OPT - Cumulative Company Assets

- debt and liquidity data:

- net income and valuation ratios data:

OPT - Company Net Income|Expected Profit Opthea Limited|OPT - P/E Multiple|Market Cap to Projected Earnings Opthea Ltd|OPT - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Opthea Ltd|OPT - Operating profit EBITDA|Net earnings per share for the last four quarters Opthea|OPT - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months opthea.com|OPT - Earnings growth in current year|Expected net earnings per share growth next year Opthea Limited

Fundamental company valuation:OPT, opthea.com

For Opthea Limited (OPT), which is developing innovative treatments for AMD, the earnings per share trend reflects the efficiency of capital management during the clinical trial period. This metric measures the percentage change in net income on a rolling year basis, revealing the business's ability to scale profitability. By analyzing this rolling year-over-year EPS chart, an investor can determine the boundaries of financial stability. Fluctuations in this indicator demonstrate the impact of investment expenditures on bottom-line profitability, allowing for an assessment of future capitalization potential upon product commercialization.

Competitor analysis for Opthea Limited